Take a look at cho website : I don't understand why they would expose themselves to expensive trials - unless the trials themselves have marketing benefit into the affluent Australian cancer market. I'm waiting for a full explanation. If nadolol is sold for $5 m will the payment be used for an NGPDT study . Are any Asian universities behind ngpdt .... ?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.6¢ |
Change
-0.004(4.00%) |
Mkt cap ! $8.199M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.6¢ | $5.005K | 50.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 75868 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 278199 | 3 |
View Market Depth
| Last trade - 15.03pm 31/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |